Table 6b.

Summary of per cent positive pens and mean Ct values from feeder trough samples and oral fluid samples by virus type across treatment and control groups collected at day 6 and day 15 post‐inoculation (DPI) from Experiment 5

Treatment	Oral Fluid 6 DPI	Oral Fluid 15 DPI	Feed 6 DPI	Feed 15 DPI
PEDV PEDV
pHorce	0% (+) a /Ct = 38.0 b	33% (+)/Ct = 30.6	50% (+)/Ct = 35.1	67% (+)/Ct = 30.8
Daafit®PLUS	0% (+)/Ct = 38.0	33% (+)/Ct = 30.0	33% (+)/Ct = 33.3	33% (+)/Ct = 32.7
Dual Defender™	0% (+)/Ct = 38.0	17% (+)/Ct = 31.5	33% (+)/Ct = 33.4	50% (+)/Ct = 30.6
FURST PROTECT	0% (+)/Ct = 38.0	33% (+)/Ct = 32.9	33% (+)/Ct = 33.9	50% (+)/Ct = 31.8
Vigilex	33% (+)/Ct = 33.8	100% (+)/Ct = 23.9	50% (+)/Ct = 34.2	100% (+)/Ct = 30.3
(+) control	100% (+)/Ct = 29.7	100% (+)/Ct = 22.8	67% (+)/Ct = 33.7	100% (+)/Ct = 29.4
PRRSV
pHorce	0% (+)/Ct = 38.0	33% (+)/Ct = 26.4	17% (+)/Ct = 26.5	67% (+)/Ct = 27.4
Daafit®PLUS	0% (+)/Ct = 38.0	33% (+)/Ct = 28.2	17% (+)/Ct = 25.8	33% (+)/Ct = 24.9
Dual Defender™	0% (+)/Ct = 38.0	33% (+)/Ct = 32.3	0% (+)/Ct = 38.0	50% (+)/Ct = 26.1
FURST PROTECT	0% (+)/Ct = 38.0	33% (+)/Ct = 28.4	17% (+)/Ct = 25.4	33% (+)/Ct = 30.4
Vigilex	100% (+)/Ct = 30.2	100% (+)/Ct = 26.4	33% (+)/Ct = 30.4	100% (+)/Ct = 29.8
(+) control	100% (+)/Ct = 29.9	100% (+)/Ct = 25.9	33% (+)/Ct = 30.9	100% (+)/Ct = 24.6
SVA
pHorce	0% (+)/Ct = 38.0	33% (+)/Ct = 31.9	17% (+)/Ct = 32.9	67% (+)/Ct = 30.7
Daafit®PLUS	0% (+)/Ct = 38.0	33% (+)/Ct = 34.5	17% (+)/Ct = 31.9	33% (+)/Ct = 31.8
Dual Defender™	0% (+)/Ct = 38.0	33% (+)/Ct = 32.9	33% (+)/Ct = 30.5	50% (+)/Ct = 32.0
FURST PROTECT	0% (+)/Ct = 38.0	17% (+)/Ct = 34.8	33% (+)/Ct = 30.9	50% (+)/Ct = 30.4
Vigilex	17% (+)/Ct = 33.9	33% (+)/Ct = 33.9	50% (+)/Ct = 32.9	100% (+)/Ct = 32.4
(+) control	50% (+)/Ct = 32.8	50% (+)/Ct = 29.1	50% (+)/Ct = 30.1	67% (+)/Ct = 30.7

^aPercentage of positive pens per room based on 6 pens per room.

^bMean Ct value across the number of pens containing positive samples.